Getting to zero new infections in children: what will it take? Dr Lee Fairlie 27 September2014

Similar documents
hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation

Dual elimination of mother-to-child transmission (MTCT) of HIV and syphilis

GARPR Online Reporting Tool

MONITORING SERVICES, PATIENTS AND PROGRAMMES

HIV Continuum of Care Monitoring Framework 2014

Mother Mentor/Mother Support Group Strategy for Expansion of Peer Support for Mothers Living with HIV

Mid-year population estimates. Embargoed until: 20 July :30

Antiretroviral therapy for HIV infection in infants and children: Towards universal access

The Botswana Combination Prevention Project (BCPP)

World Health Day Diabetes and RMNCAH in Africa: R for Reproductive Health

Stigma and discrimination as barriers to achievement of global PMTCT and maternal health goals

HIV and Infant Cancer - An Empirical Research

International Service Program

Frequently Asked Questions (FAQs)

Consolidated guidelines on the use of antiretroviral drugs for treating

KENYA, COUNTY HIV SERVICE DELIVERY PROFILES

HPTN 073: Black MSM Open-Label PrEP Demonstration Project

2. Options B and B+: a simplified approach to integrated PMTCT & ART at the primary care level

children and THE GAP REPORT 2014

Rapid Assessment of Sexual and Reproductive Health

Global Update on HIV Treatment 2013: Results, Impact and Opportunities

Statistical release P0302

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.

150 7,114, making progress

Prevention of mother-to-child transmission of HIV/AIDS programmes

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2013

NSW Pertussis Control Program 2015

The Data Improvement Guide. A curriculum for improving the quality of data in PMTCT

HIV/AIDS: General Information & Testing in the Emergency Department

Statistical release P0302

New York State Strategic Plan for. Elimination of Mother-to-Child Transmission of HIV

Statistical release P0302

Peer Educators Take Family Planning Messages to HIV-Positive Support Groups

68 3,676, making progress

Promoting Family Planning

Participant Manual Trainer Manual Presentation Booklet

Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers

IV. Counseling Cue Cards. ICAP International Center for AIDS Care and Treatment Mailman School of Public Health Columbia University

Rapid Assessment of Sexual and Reproductive Health

Aids Fonds funding for programmes to prevent HIV drug resistance

- % of participation - % of compliance. % trained Number of identified personnel per intervention

Post-2015 Negotiation Briefs #8: Youth Friendly Services in Universal Health Coverage

Operations Manual. for Delivery of HIV Prevention, Care and Treatment at Primary Health Centres in High-Prevalence, Resource-Constrained Settings

Process Monitoring. 6 th. th Asia-Pacific UN PMTCT Task Force Meeting Kuala Lumpur, Malaysia Nepal Country Team

117 4,904, making progress

UNAIDS 2014 LESOTHO HIV EPIDEMIC PROFILE

HIV/AIDS Tool Kit. B. HIV/AIDS Questionnaire for Health Care Providers and Staff

Sample Breastfeeding Policy for Health Services in the Community

GUIDANCE ON GLOBAL SCALE-UP OF THE PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV

HIV New Diagnoses, Treatment and Care in the UK 2015 report

UK prevalence in pregnancy and risk of transmission

Saving women s lives: the health impact of unsafe abortion

Whooping cough and pregnancy

Prevention of Pertussis Among Pregnant & Post Partum Women and Their Infants. Marilyn Michels RN MSN CIC Kathleen Curtis MS RN

The Basics of Drug Resistance:

ORGANIZATIONS. Organization Programmatic Areas of Focus Notes Interviewed? Yes. Averting Maternal Death and Disability (AMDD)

Clinical rationale for viral load testing

Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, 2004 Interim Progress Report

MATERNAL AND CHILD HEALTH

Preventing Mother-to-Child Transmission (MTCT)

Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014

Maternal and Neonatal Health in Bangladesh

Published by the Department of Health Private Bag X828 Pretoria 0001 South Africa. Copyright: Department of Health, Republic of South Africa

Case Finding for Hepatitis B and Hepatitis C

Health Systems Strengthening and Integration of FP/MNCH in Uganda The experience of MSH STRIDES project

Bachelor s degree in Nursing (Midwifery)

Rapid Assessment of Sexual and Reproductive Health

Chapter 13. Structuring Health Services to Meet Women s Needs

Yes, I know I have genital herpes:

Delaying First Pregnancy

Unplanned Pregnancy Family Planning Alliance

countdown to zero Believe it. Do it.

Special Considerations

General information about HIV

Brief Overview of MIRA Channel (Women Mobile Lifeline Channel)

III CHAPTER 2. Antenatal Care. Ornella Lincetto, Seipati Mothebesoane-Anoh, Patricia Gomez, Stephen Munjanja

MATARA. Geographic location 4 ( ) Distribution of population by wealth quintiles (%), Source: DHS

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED

Aetna Life Insurance Company

HIV AND ADOLESCENTS: HIV TESTING AND COUNSELLING, TREATMENT AND CARE FOR ADOLESCENTS LIVING WITH HIV SUMMARY OF KEY FEATURES AND RECOMMENDATIONS

Dublin Declaration. on Partnership to fight HIV/AIDS in Europe and Central Asia

End-of-Project Technical Report. 13 October 2014

The Western Cape Consolidated Guidelines for HIV Treatment: Prevention of Mother- to- Child Transmission of HIV (PMTCT), Children, Adolescents and

PREVENTIVE HEALTHCARE GUIDELINES INTRODUCTION

National Antiretroviral Treatment Guidelines

BRIEF FOR PARLIAMENTARIANS ON HIV AND AIDS. Towards an HIV-free generation: Ending the vertical transmission of HIV

Vaccination against pertussis (Whooping cough) for pregnant women Information for healthcare professionals

South African Health Sector: Presented to Budget committee By Dr. Olive Shisana CEO Human Sciences Research Council

BRITISH COLUMBIA GUIDELINES FOR THE CARE OF HIV POSITIVE PREGNANT WOMEN AND INTERVENTIONS TO REDUCE PERINATAL TRANSMISSION

UNAIDS ISSUES BRIEF 2011 A NEW INVESTMENT FRAMEWORK FOR THE GLOBAL HIV RESPONSE

Tdap booster vaccine for Health Care Workers Frequently Asked Questions for Health Professionals

on Prevention of Mother-To-Child Transmission (PMTCT) of HIV

PERINATAL HIV. AIIMS- NICU protocols Sunil Saharan 1, Rakesh Lodha 2, Ramesh Agarwal 2, Ashok Deorari 3, Vinod Paul 3 1

ZIMBABWE NATIONAL HIV AND AIDS STRATEGIC PLAN (ZNASP)

Data Visualization That Works Facilitating HIV Program Targeting: Case Examples and Considerations

Risks Factors for Teenage Pregnancy and The Youth Perspective on Teenage Pregnancy and Health Needs in Nkalashane, Swaziland

Dr.Archana Patel 1,2 1. Lata Medical Research Foundation, Nagpur, India 2. Indira Gandhi Government Medical College, Nagpur, India

Iowa s Maternal Health, Child Health and Family Planning Business Plan

HIV Guidelines. New Strategies.

Transcription:

Getting to zero new infections in children: what will it take? Dr Lee Fairlie 27 September2014

Content What will it take from us individually? Back to basics Pressure points for PMTCT What else do we need? Conclusions

What will it take from us??? A good attitude Hard work Dedication An ongoing effort to teach and a desire to learn Change management processes Commitment to strengthen the health system 1 person at a time

You must be the change you wish to see in the world. Mahatma Gandhi

START WITH THE BASICS

HIV Incidence 2012 by age and sex A quarter of all new HIV infections in this age group Incidence 4 times higher in females than in males 15-24y

Maternal SRH Overall the couple year protection rate has increased from 26.3% (2002/3) to 37.8% (2013/4) Injectables account for about 47% of the couple year protection rate Cervical screening rate in 2012/2013 55.4% (> National target of 54%)

Male condom distribution rate: Number of condoms/male > 15 years

REGARDING EMTCT PRACTICES..

HIV testing in pregnancy Insert ANC prevalence graphs here

We have excellent guidelines BUT.. They need to be followed closely They are sometimes complicated and misunderstood There needs to be ongoing training with reinforcement and evaluation to ensure that they are understood Numerous pressure points that require focus to eliminate MTCT

Where are the pressure points antenatally?? Early booking Testing in pregnancy PMTCT access < 20 weeks First visit Every 3 months if negative cart CD4

What are the pressure points postnatally?? Infant Birth testing Infant feeding Infant prophylaxis Infant testing Infant access to ART if + High risk infants EBF NVP 6-12 weeks High risk infants Birth 6 weeks Post BF 18 months All < 5 years Urgent < 12 months Woman Maternal contraception and SRH Maternal retention on cart Maternal Viral suppression Maternal retesting if negative FP PAP smear STI New guidelines VL testing for all Tracing mechanisms 3 monthly

Early bookings Issues: Booking at GPs -> Unclear if HIV testing and full PMTCT package offered Poor referral mechanisms between GPs and ANC Some facilities turn clients away without offering HIV testing and FDC where appropriate Lack of resources at facilities Cultural reasons for late booking Data recording- PMTCT policy requires HIV-positive pregnant women book before 14 wks gestation- yet DHIS data records booking before 20 weeks

1/3 of districts reach National average of 44% 19/52 districts below 50 % (National target)

Interventions for Early Booking Increasing early attendance requires interventions at both the individual and community levels to raise demand for services Changes in attitudes towards health-care services Changes in organization of ANC services to boost early uptake e.g. CHWs to recruit women in the community

HIV Testing in Pregnancy SA PMTCT Survey 2012

Access to PMTCT UNAIDS: 234 955 pregnant women received ART for PMTCT 2012 83% [75%-90%] need met UNAIDS Global report 2013

HIV re-testing during pregnancy 3 monthly National target 70 % Generally falling below this Increases risks for MTCT

Percentage% 70 60 50 40 30 20 10 0 DKK ANC HIV Retest Rate Oct 13 June 14 Qrt 1 Qrt 2 Qrt 3 Target 59.3 61.5 58.5 65.3 55.3 56.3 44.6 44.1 44.9 41.9 41.7 38.1 Maquassi Matlosana Tlokwe Ventersdorp Qrt 1 44.6 41.9 56.3 44.9 Qrt 2 44.1 55.3 59.3 41.7 Qrt 3 38.1 58.5 61.5 65.3 Matlosana has improved from 41.9% in Q1 to 58.5% in Q3. Wits RHI DKK team

Number 8 7 6 5 4 3 2 1 0 4.8 3.4 2.8 5.8 2.8 2.1 Maquassi Matlosana Tlokwe Ventersdorp Qrt 1 4.8 5.8 2.3 4.2 Qrt 2 3.4 2.8 3.6 3.1 Qrt 3 2.8 2.1 0.7 7.1 Source: DHIS June 2014 DKK ANC HIV retest positivity rate Oct 13 June 14 Qrt 1 Qrt 2 Qrt 3 2.3 3.6 Wits RHI DKK team 0.7 4.2 3.1 7.1

Infant feeding 89% of women receive feeding counselling 4-8 weeks: 35.5% exclusive breastfeeding significant increase from 20.4% reported in 2010 47.1% reported avoiding breastmilk (reduction from the 61.5% in 2010) Horwood: 58.9% adult and 50% adolescent women EBF SAPMTCT 2012 Horwood. PLoS ONE. 2012

Birth testing Need to consider birth PCR in other high risk newborns such as where mother unbooked/ presented late/in labour or has an elevated VL/ low CD4 count Standard Treatment Guidelines and EDL Hospital care 2013

Infant prophylaxis Daily NVP for 6-12 weeks BUT the question is around high risk infants: Kaletra: Black box warning in under 14 days of age (post conception) Prems need to wait until term + 14 days before starting Kaletra according to FDA 42.4% (v/v) alcohol and 15.3% (w/v) propylene glycol, risk multi-organ toxicity NVP: Potential resistance issues; decreased effectiveness in young children regardless of exposure NRTIs No dose for ABC in < 3 months Should use AZT/3TC as backbone

NHLS July 2014

NHLS data July 2014

Infant testing: 6 week transmission 6 weeks: NHLS data shows that PMTCT practices successful provided HIV infected mothers access and are retained in care BUT need to be aware of high risk populations such as adolescents Horwood 2008/9 et al: Infants infected with HIV higher amongst adolescent mothers (35/325, 10.8%) compared to adult mothers (185/2800, 6.6%) Horwood et al. PLoS ONE. 2013

Note: The area with the 2 nd lowest ANC prevalence has the highest HIV PCR + rate: We must beware of complacency in these areas!!!

18 month testing Kheth Impilo(KI): KwaZulu-Natal, Mpumalanga and the Eastern Cape 64.5% reduction in 18-month HIV test positivity declining from 10.7% to 3.8% Relative proportion of children receiving 18- month HIV tests versus 6-week PCR tests was low, but improved during the last quarter from 19.1% to 24.4% HPTN 046: 18 month transmission 2.2% in 6m NVP arm; 3.1% 6 week NVP arm 9 month testing: WHO guidelines, not yet SA Grimwood. SAMJ. 2012 Fowler. JAIDS. 2014

18 month testing HSRC survey 2012

Percentage 7 6 5 4 3 2 1 0 DKK Infant Antibody HIV test around 18 months positive rate Oct 13 June 14 2 0 3.9 3.8 6.1 4.8 Maquassi Matlosana Tlokwe Ventersdorp Qrt 1 2 3.8 0 1.6 Qrt 2 0 6.1 0 4.3 Qrt 3 3.9 4.8 1.2 4.9 Source: DHIS June 2014 Qrt 1 Qrt 2 Qrt 3 0 0 1.2 1.6 4.3 4.9 Wits RHI DKK team

Infant access to cart if + 148 342 children were on cart 2012/3 Estimated need is 220 000 (UNAIDS 2012) 63% of children needing cart access it

Outcomes of Infants starting ART in SA 2004-2012 M Porter et al. SA HIV CS Conf. 2014

Maternal retention in care and VL suppression High loss to follow up rate post delivery and breastfeeding with option B A pooled analysis, estimate of 73.5% of pregnant women with adequate (>80%) ART adherence Proportion higher during the antepartum (75.7%) compared to postpartum (53.0%) Need to address these issues before introducing option B+ Programmatically in SA: VL suppression rates not known as currently not part of guidelines-> cart as prophylaxis only Nachega. AIDS. 2012

Maternal 3 monthly HIV testing Mozambique: Post partum HIV acquisition: incidence 3.2/100 woman years Highest incidence 4.9/100 woman-years in 18-19 year olds In newly infected, transmission rate 21% EPI visits ideal time for retesting but not routine currently De Schacht. JIAS. 2014

WHAT ELSE DO WE NEED???

Good data Need to evaluate our progress critically and not get to zero just because we have no stats available! Need to document best practices especially with implementing: - option B+ - 9 month testing in infants - Adherence tools and aids Probably need increased resources such as counsellors to ensure that HIV testing is done during ANC and PNC for both women and child; data capturers etc.

Conclusions Getting to zero will need a combined effort but also each person realizing their part We need to remember basics and primarily intensify efforts around preventing HIV infection and unintended pregnancy We need to intensify our efforts around the poor performing areas of the programme We need to plan ahead for B+ We need to think creatively about adherence in pregnant and breastfeeding women The guidelines are excellent BUT they need to be implemented (and understood) and we need data to evaluate them!

Acknowledgements NHLS for the EID data IeDEA and Drs M Porter and MA Davies Dr N Chandiwana Dr G Kgosana